1. Home
  2. BDSX vs LWLG Comparison

BDSX vs LWLG Comparison

Compare BDSX & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • LWLG
  • Stock Information
  • Founded
  • BDSX 2005
  • LWLG 1991
  • Country
  • BDSX United States
  • LWLG United States
  • Employees
  • BDSX N/A
  • LWLG N/A
  • Industry
  • BDSX Precision Instruments
  • LWLG Containers/Packaging
  • Sector
  • BDSX Health Care
  • LWLG Industrials
  • Exchange
  • BDSX Nasdaq
  • LWLG Nasdaq
  • Market Cap
  • BDSX 115.4M
  • LWLG 126.0M
  • IPO Year
  • BDSX 2020
  • LWLG N/A
  • Fundamental
  • Price
  • BDSX $0.61
  • LWLG $0.98
  • Analyst Decision
  • BDSX Strong Buy
  • LWLG
  • Analyst Count
  • BDSX 3
  • LWLG 0
  • Target Price
  • BDSX $2.93
  • LWLG N/A
  • AVG Volume (30 Days)
  • BDSX 276.1K
  • LWLG 915.5K
  • Earning Date
  • BDSX 05-07-2025
  • LWLG 03-18-2025
  • Dividend Yield
  • BDSX N/A
  • LWLG N/A
  • EPS Growth
  • BDSX N/A
  • LWLG N/A
  • EPS
  • BDSX N/A
  • LWLG N/A
  • Revenue
  • BDSX $71,323,000.00
  • LWLG $95,605.00
  • Revenue This Year
  • BDSX $32.90
  • LWLG N/A
  • Revenue Next Year
  • BDSX $24.65
  • LWLG N/A
  • P/E Ratio
  • BDSX N/A
  • LWLG N/A
  • Revenue Growth
  • BDSX 45.30
  • LWLG 136.05
  • 52 Week Low
  • BDSX $0.59
  • LWLG $0.98
  • 52 Week High
  • BDSX $2.04
  • LWLG $4.64
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 33.15
  • LWLG 38.43
  • Support Level
  • BDSX $0.63
  • LWLG $0.98
  • Resistance Level
  • BDSX $0.78
  • LWLG $1.31
  • Average True Range (ATR)
  • BDSX 0.07
  • LWLG 0.11
  • MACD
  • BDSX -0.01
  • LWLG 0.01
  • Stochastic Oscillator
  • BDSX 9.13
  • LWLG 0.03

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.

Share on Social Networks: